| 2024-04 |
Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease |
European Journal of Gastroenterology and Hepatology
|
| 2024-03 |
Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea |
Intestinal research
|
| 2024-03 |
Impact of age at diagnosis on long-term prognosis in patients with intestinal Behçet's disease |
Journal of Gastroenterology and Hepatology
|
| 2024-03 |
A Comprehensive Understanding of Post-Translational Modification of Sox2 via Acetylation and O-GlcNAcylation in Colorectal Cancer |
Cancers
|
| 2024-03 |
Effectiveness and Tolerability of Methotrexate Combined with Biologics in Patients with Crohn’s Disease: A Multicenter Observational Study |
Digestive Diseases and Sciences
|
| 2024-01 |
New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases |
Therapeutic Advances in Gastroenterology
|
| 2024-01 |
Which biomarkers best reflect the degree of inflammation in Crohn’s disease? |
Intestinal research
|
| 2023-10 |
The global, regional, and national burden of inflammatory bowel diseases, 1990-2019: A systematic analysis for the global burden of disease study 2019 |
DIGESTIVE AND LIVER DISEASE
|
| 2023-10 |
Clinical characteristics and risk factors related to polyposis recurrence and advanced neoplasm development among patients with non-hereditary colorectal polyposis |
Intestinal research
|
| 2023-08 |
Effectiveness and tolerability of methotrexate monotherapy in Crohn’s disease patients: a multicenter observational study |
Therapeutic Advances in Gastroenterology
|
| 2023-07 |
How have treatment patterns for patients with inflammatory bowel disease changed in Asian countries? |
Intestinal research
|
| 2023-05 |
Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease |
Gut and Liver
|
| 2023-04 |
Feasibility of a Clinical Decision Support Tool for Ustekinumab to Predict Clinical Remission and Relapse in Patients With Crohn's Disease: A Multicenter Observational Study |
Inflammatory Bowel Diseases
|
| 2023-03 |
Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet's disease |
Arthritis research & therapy
|
| 2023-03 |
Long‐term clinical outcomes of intestinal Behçet's disease: A 30‐year cohort study at a tertiary hospital in South Korea |
Journal of Gastroenterology and Hepatology
|
| 2023-03 |
Early Infliximab Trough Levels Predict the Long-term Efficacy of Infliximab in a Randomized Controlled Trial in Patients with Active Crohn?s Disease Comparing, between CT-P13 and Originator Infliximab |
Gut and Liver
|
| 2023-02 |
Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy |
Yonsei Medical Journal
|
| 2023-02 |
Analysis of the gut microbiome using extracellular vesicles in the urine of patients with colorectal cancer |
Korean Journal of Internal Medicine
|
| 2023-01 |
소장질환에서의 기구보조 소장내시경의 이용: 전문가 합의문 |
The Korean Journal of Gastroenterology
|
| 2022-11 |
Histologic Evaluation Using the Robarts Histopathology Index in Patients With Ulcerative Colitis in Deep Remission and the Association of Histologic Remission With Risk of Relapse |
INFLAMMATORY BOWEL DISEASES
|
| 2022-08 |
Anti-inflammatory properties of butyrate-producing atypical Escherichia coli in a murine colitis model |
Intestinal research
|
| 2022-08 |
Usefulness of Examining Various Patient-Reported Outcomes in Predicting Endoscopic Mucosal Healing in Ulcerative Colitis |
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
|
| 2022-07 |
Updates on conventional therapies for inflamma-tory bowel diseases: 5-aminosalicylates, cortico-steroids, immunomodulators, and anti-TNF-alpha |
The Korean Journal of Internal Medicine
|
| 2022-06 |
Tumor-Suppressive Effect of Metformin via the Regulation of M2 Macrophages and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment of Colorectal Cancer |
Cancers
|
| 2022-05 |
Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence |
GUT AND LIVER
|
| 2022-05 |
Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease: prognosis prediction and mutual agreement |
The Korean Journal of Internal Medicine
|
| 2022-04 |
Histological Diagnostic Yield and Clinical Significance of the First Biopsy in Device-Assisted Enteroscopy in Patients with Small Bowel Diseases: A KASID Multicenter Study |
Diagnostics
|
| 2022-04 |
Rebleeding Rate and Risk Factors for Rebleeding after Device-Assisted Enteroscopy in Patients with Obscure Gastrointestinal Bleeding: A KASID Multicenter Study |
Diagnostics
|
| 2022-03 |
Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatment |
BMC GASTROENTEROLOGY
|
| 2022-01 |
Which biologic agents increase perioperative complications in patients with inflammatory bowel disease? |
Intestinal research
|
| 2022-01 |
Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study |
PLoS ONE
|
| 2021-11 |
Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis |
GUT AND LIVER
|
| 2021-10 |
Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model |
Intestinal research
|
| 2021-10 |
An Escherichia coli strain with extra catalase activity protects against murine colitis by scavenging hydrogen peroxide and regulating regulatory t cell/interleukin-17 pathways |
FREE RADICAL BIOLOGY AND MEDICINE
|
| 2021-09 |
Fecal Microbiota and Gut Microbe-Derived Extracellular Vesicles in Colorectal Cancer |
FRONTIERS IN ONCOLOGY
|
| 2021-09 |
Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease? |
GUT AND LIVER
|
| 2021-08 |
Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
| 2021-07 |
Resting heart rate is associated with colorectal advanced adenoma |
PLOS ONE
|
| 2021-05 |
Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet's disease from Crohn's disease |
SCIENTIFIC REPORTS
|
| 2021-02 |
Incidence and Prevalence of Inflammatory Bowel Disease across Asia |
YONSEI MEDICAL JOURNAL
|
| 2020-10 |
Quantitative Proteomic Analysis of the Expression of SARS-CoV-2 Receptors in the Gut of Patients with Chronic Enterocolitis |
YONSEI MEDICAL JOURNAL
|
| 2020-06 |
Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease |
PLOS ONE
|